Windtree Therapeutics Stock Price To Sales
WINT Stock | USD 0.13 0.00 0.00% |
Windtree Therapeutics fundamentals help investors to digest information that contributes to Windtree Therapeutics' financial success or failures. It also enables traders to predict the movement of Windtree Stock. The fundamental analysis module provides a way to measure Windtree Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Windtree Therapeutics stock.
Last Reported | Projected for Next Year | ||
Price To Sales Ratio | 666.48 | 633.15 |
Windtree | Price To Sales |
Windtree Therapeutics Company Price To Sales Analysis
Windtree Therapeutics' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Windtree Therapeutics Price To Sales | 660.53 X |
Most of Windtree Therapeutics' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Windtree Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Windtree Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Windtree Therapeutics is extremely important. It helps to project a fair market value of Windtree Stock properly, considering its historical fundamentals such as Price To Sales. Since Windtree Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Windtree Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Windtree Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Windtree Price To Sales Historical Pattern
Today, most investors in Windtree Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Windtree Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Windtree Therapeutics price to sales as a starting point in their analysis.
Windtree Therapeutics Price To Sales |
Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition |
Windtree Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Windtree Therapeutics has a Price To Sales of 660 times. This is much higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The price to sales for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
All Next | Launch Module |
Windtree Fundamentals
Return On Equity | -1.51 | ||||
Return On Asset | -0.45 | ||||
Current Valuation | 917.64 K | ||||
Shares Outstanding | 8.75 M | ||||
Shares Owned By Insiders | 0.27 % | ||||
Shares Owned By Institutions | 0.59 % | ||||
Number Of Shares Shorted | 909.04 K | ||||
Price To Earning | (0.05) X | ||||
Price To Book | 0.27 X | ||||
Price To Sales | 660.53 X | ||||
Gross Profit | (17.79 M) | ||||
EBITDA | (20.16 M) | ||||
Net Income | (20.29 M) | ||||
Cash And Equivalents | 11.38 M | ||||
Cash Per Share | 0.37 X | ||||
Total Debt | 16.83 M | ||||
Debt To Equity | 0.95 % | ||||
Current Ratio | 2.47 X | ||||
Book Value Per Share | 5.90 X | ||||
Cash Flow From Operations | (13.44 M) | ||||
Short Ratio | 0.06 X | ||||
Earnings Per Share | (19.03) X | ||||
Target Price | 7.0 | ||||
Beta | 0.64 | ||||
Market Capitalization | 4.92 M | ||||
Total Asset | 32.41 M | ||||
Retained Earnings | (844.82 M) | ||||
Working Capital | 1.38 M | ||||
Current Asset | 40.79 M | ||||
Current Liabilities | 11.07 M | ||||
Net Asset | 32.41 M |
About Windtree Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Windtree Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Windtree Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Windtree Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Windtree Stock Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.